Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Saved in:

Bibliographic Details
Main Authors:	Hang Li, Hua Lu, Xi-Ping Shen, Xiao-Song Li
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2025-01-01
Series:	Clinical and Molecular Hepatology
Subjects:	hepatocellular carcinoma portal vein tumor thrombosis transarterial radioembolization tyrosine kinase inhibitor
Online Access:	http://e-cmh.org/upload/pdf/cmh-2024-0832.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
by: Moon Haeng Hur, et al.
Published: (2025-01-01)

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01)

Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection
by: Amelia Wong, et al.
Published: (2024-08-01)

Identifying key predictors of mortality and liver decompensation in hepatocellular carcinoma patients treated with transarterial radioembolization
by: Mohammad Arabi, et al.
Published: (2025-05-01)

Efficacy and safety analysis of DEB-TACE for hepatocellular carcinoma with portal vein tumor thrombosis
by: Yan Zhang, et al.
Published: (2025-06-01)

Price Analysis of Systemic Therapies and Transarterial Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma
by: Abimbola O. Williams, et al.
Published: (2025-05-01)

Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis
by: Kun-Ming Chan, et al.
Published: (2025-04-01)

Transarterial chemoembolization combined with tyrosine kinase inhibitors and/or immune checkpoint inhibitors induced hypothyroidism is associated with improved overall survival in hepatocellular carcinoma
by: Shengyuan Xu, et al.
Published: (2025-05-01)

Immune-Targeted Therapy with or without Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (PVTT): A Multicenter Retrospective Study
by: Ran You, et al.
Published: (2024-09-01)

A Rare Case of Portal Vein Thrombosis Due to Portal Vein Aneurysm. Case Report and the Review of the Literature
by: J. Arudchelvam
Published: (2024-12-01)

PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy
by: Fei Cao, et al.
Published: (2025-06-01)

Prognosticators of hepatocellular carcinoma with intrahepatic vascular invasion
by: Yuan-Chen Lo, et al.
Published: (2019-01-01)

Phosphorus-32 microspheres: A dual-modality transarterial radioembolization approach for hepatocellular carcinoma therapy and Anti-PD1 immunotherapy potentiation
by: Shipeng Dai, et al.
Published: (2025-10-01)

Diagnosis and Management of Portal Vein Thrombosis in Liver Cirrhosis
by: Cynthia Kurniawan, et al.
Published: (2025-04-01)

Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis
by: Xu Li, et al.
Published: (2024-09-01)

Health Outcomes and Resource Consumption Analysis of Radioembolization with Y90 Glass Microspheres (TARE-Y90) Versus Transarterial Chemoembolization with Irinotecan (DEBIRI) in Patients with Liver Metastases from Colorectal Cancer in Spain
by: Juan José Ciampi-Dopazo, et al.
Published: (2025-03-01)

Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: a systematic review and meta-analysis
by: Hengyu Tian, et al.
Published: (2025-04-01)

Portal Hypertension Unmasked—Cavernous Transformation of the Portal Vein Following Portal Vein Thrombosis in a 9‐Year‐Old Female: A Case Report
by: Areej Motasim Khalil Seedahmed, et al.
Published: (2025-01-01)

Portal vein thrombosis in patients with liver cirrhosis
by: Savić Željka, et al.
Published: (2024-01-01)

Transarterial Radioembolization for Hepatocellular Carcinoma in Korea: Current Clinical Practices, Facility Requirements, and Patient Selection
by: Dongho Hyun
Published: (2025-07-01)

First-line treatment of hepatocellular carcinoma: a propensity-matched analysis of tyrosine kinase inhibitors combined with TACE, with or without PD-1 inhibitors
by: Yanjun Shen, et al.
Published: (2025-05-01)

Health-related quality of life and survival of patients with hepatocellular carcinoma treated with transarterial chemoembolization and Yttrium-90
by: Kathryn Bress, et al.
Published: (2025-04-01)

99mTc/90Y radiolabeled biodegradable gel microspheres for lung shutting fraction assessment and radioembolization in hepatocellular carcinoma theranostics
by: Yi Dong, et al.
Published: (2024-12-01)

Management of hepatocellular carcinoma prior to liver transplantation: latest developments
by: Antoine Robert, et al.
Published: (2025-12-01)

Efficacy and safety of image-guided hypofractionated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective, multicenter study
by: Sang Min Lee, et al.
Published: (2025-04-01)

Portal vein thrombosis after double installation of transjugular intrahepatic portosystemic stent (clinical observation)
by: M. S. Guska, et al.
Published: (2024-04-01)

Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis
by: Jeayeon Park, et al.
Published: (2025-01-01)

Percutaneous transhepatic embolization of gastro-esophageal varices for the treatment of variceal bleeding in portal vein thrombosis secondary to hepatocellular carcinoma: A case report
by: Amol S. Rathod, et al.
Published: (2025-06-01)

Protein C in a patient with portal vein thrombosis in liver transplantation
by: S. V. Zhuravel, et al.
Published: (2021-06-01)

Complications of Radioembolization: Prevention and Management
by: Gyoung Min Kim
Published: (2025-07-01)

Surgical management in hepatocellular carcinoma with portal vein tumour thrombosis: is this the end of the road or a chance to expand the criteria for resectability?
by: Nikolaos Benatatos, et al.
Published: (2022-07-01)

Lenvatinib combined with anti-PD-1 antibodies plus locoregional treatment for initial unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter real-world study
by: Qi-Yu Chi, et al.
Published: (2025-07-01)

Endovascular intervention for portal vein system thrombosis in a patient with protein S deficiency: A case report
by: Min Jeong Choi, et al.
Published: (2025-04-01)

Ultrasound contrast microbubbles to predict the microsphere distribution during transarterial radioembolization with holmium microspheres, an in vitro proof of concept study
by: Jan L. van der Hoek, et al.
Published: (2025-12-01)

Successful liver transplantation from a donor with occlusive portal vein thrombosis
by: M. S. Novruzbekov, et al.
Published: (2023-09-01)

Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
by: Yuki Koga, et al.
Published: (2018-08-01)

MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
by: Maria Anna Guardascione, et al.
Published: (2009-11-01)

MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
by: Lucio Amitrano, et al.
Published: (2009-11-01)

Induction hepatic arterial infusion chemotherapy followed by surgery for hepatocellular carcinoma with massive portal vein tumor thrombosis: a case series of 20 patients
by: Yuta Kimura, et al.
Published: (2025-05-01)

Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
by: Yuki Ohya, et al.
Published: (2020-12-01)